For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and
the preservation of quality of life play a crucial role over the entire therapy period. In MS …

Background Neurological disorders remain a worldwide concern due to their increasing
prevalence and mortality, combined with the lack of available treatment, in most cases …

Abstract Background The Symbol Digit Modalities Test (SDMT), the most reliable and
sensitive measure of cognition in people with multiple sclerosis (PwMS), is increasingly …

Background Cognitive impairment (CI) is one of the most prevalent symptoms of multiple
sclerosis (MS). However, it is difficult to include cognitive assessment as part of MS standard …

Background: Treatment guidelines recommend early disease-modifying therapy (DMT)
initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies that …

Internet-connected devices, including personal computers, smartphones, smartwatches, and
voice assistants, have evolved into powerful multisensor technologies that billions of people …

Registries have the potential to tackle some of the current limitations in determining the long-
term impact of multiple sclerosis. Online assessments using patient-reported outcomes can …

Background Cognitive problems affect up to 70% of people with multiple sclerosis (MS),
which can negatively impact mood, ability to work, and quality of life. Addressing cognitive …

Introduction: Huntington disease (HD) is an autosomal dominant neurodegenerative
disorder manifested by motor, behavioural and cognitive deficits with fatal consequences …

For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and
the preservation of quality of life play a crucial role over the entire therapy period. In MS …